The University of Chicago and UChicago Medicine are part of a new health research accelerator that has launched thanks to nearly $35 million from the National Institutes of Health.
The Institute for Translational Medicine will work to improve people’s lives by pursuing research breakthroughs and getting those discoveries into the real world.
“This vital initiative will help drive research and discovery that can greatly and more efficiently benefit the health of our patients and surrounding communities,” said Kenneth Polonsky, dean and executive vice president of medical affairs at the University of Chicago. “We look forward to leveraging these new opportunities, technologies and the robust network of resources now available to our medical and academic communities—as well as to our local community partners—to continue to advance medicine that makes a difference in people’s lives.”
The ITM is a partnership between the University of Chicago and Rush in collaboration with Advocate Health Care, the Illinois Institute of Technology, Loyola University Chicago and NorthShore University HealthSystem that’s fueled by millions of dollars in funding from the NIH’s National Center for Advancing Translational Sciences. Over the next five years, the funding will help researchers, the public, government, industry and nonprofits work together to improve the health of Chicagoland residents.
“The ITM supports clinical and translational research in so many ways,” said Julian Solway, dean for Translational Medicine at the University of Chicago and one of the ITM three principal investigators. “We’re thrilled to launch this organized effort and work with such great allies to speed up the innovation pipeline.”